News Daily News Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis L.A. McKeown March 01, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024
News Daily News New Scientific Statement Focuses on Below-the-Knee Technical Challenges L.A. McKeown January 19, 2024
News Daily News TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable Michael O'Riordan January 09, 2024
News Conference News AHA 2023 Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina Michael O'Riordan November 11, 2023
News Conference News TCT 2023 Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door? L.A. McKeown October 24, 2023
News Conference News LINC 2023 Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil L.A. McKeown June 09, 2023
News Conference News SCAI 2023 SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year L.A. McKeown May 31, 2023
News Conference News EAS 2023 Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1 Michael O'Riordan May 25, 2023
News Conference News SCAI 2023 Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis L.A. McKeown May 22, 2023
News Conference News EuroPCR 2023 ‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise Michael O'Riordan May 18, 2023
News Conference News ACC 2023 Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes Michael O'Riordan March 04, 2023
News Conference News Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices L.A. McKeown November 18, 2022
News Features From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine L.A. McKeown October 18, 2022
News Conference News TCT 2022 FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years L.A. McKeown September 20, 2022
News Conference News TCT 2022 SCAAR Registry Delves Into Left Main Revascularization Outcomes Michael O'Riordan September 19, 2022
News Daily News COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK Michael O'Riordan September 15, 2022